HSIL - Hemant Surgical Industries Limited Share Price

Healthcare Equipment & Supplies

₹537.00-10.70(-1.95%)

Market Closed as of Apr 13, 2026, 15:30 IST

Select time range

Pros

Past Returns: In past three years, the stock has provided 12.6% return compared to 10.2% by NIFTY 50.

Momentum: Stock price has a strong positive momentum. Stock is up 104.1% in last 30 days.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Cons

Size: It is a small market cap company and can be volatile.

Insider Trading: Significant insider selling noticed recently.

Dividend: Stock hasn't been paying any dividend.

Valuation
Market Cap	351.91 Cr
Price/Earnings (Trailing)	113.09
EV/EBITDA	71
Price/Free Cashflow	101.91
MarketCap/EBT	86.86
Enterprise Value	278.74 Cr

Profitability
Free Cashflow Yield	0.98%

Growth & Returns
Price Change 1W	7.4%
Price Change 1M	104.1%
Price Change 6M	-38.2%
Price Change 1Y	414.8%
3Y Cumulative Return	12.6%
5Y Cumulative Return	28.2%
7Y Cumulative Return	32.2%
10Y Cumulative Return	20.2%

Balance Sheet
Total Assets	214.02 Cr
Current Assets	154.38 Cr
Current Liabilities	72.96 Cr
Inventory	37.11 Cr

Technical Indicators
RSI (14d)	50.49
RSI (5d)	68.31
RSI (21d)	54.86
MACD Signal	Buy
Stochastic Oscillator Signal	Sell
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Shareholder Name	Holding %
HANSKUMAR SHAMJI SHAH	27.05%
KAUSHIK HANSKUMAR SHAH	16.13%
HEMANT PRAFUL SHAH	13.3%
Singularity Large Value Fund I	3.83%
Wealthwave Capital Fund	3.07%
SURESH ZUNZUNWALA	2.58%
MONA LAROIA	2.52%
Swati Pokharna	2.3%
Renudevi Hisaria	2.3%
Singularity Large Value Fund III	1.91%
Singularity Equity Fund I	1.91%
PM Investment	1.53%
HARSHA VENKATESH	0.84%
SACHIN KUMAR BHARTIYA	0.8%
Upahar Homfin Private Limited	0.77%
Free India Assurance Services Limited	0.77%
Naresh Saraaf	0.77%
NAMAN HEMANT SHAH	0.73%
LEENA HANSKUMAR SHAH	0.67%
NEHA HANSKUMAR SHAH	0.6%

Revenue From Operations	-
Other income	-
Cost of Materials	-
Employee Expense	-
Finance costs	-
Other expenses	-
Total Expenses	-
Total profit before tax	-
Current tax	-
Deferred tax	-
Tax expense	-
Net profit (loss) for the period	-
Earnings Per Share, Basic	-
Earnings Per Share, Diluted	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Revenue From Operations	1%	107	106	1,853	1,859	2,710	2,285
Other income	24.2%	5.11	4.31	28	20	30	9.71
Total Revenue	-	-	110	-	-	-	-
Cost of Materials	17.7%	94	80	728	726	620	417
Purchases of stock-in-trade	-	0	0	0.01	46	511	547
Employee Expense	26.2%	9.33	7.6	223	227	360	309
Finance costs	4100%	2.2	0.97	72	73	87	56
Other expenses	33.3%	13	10	581	671	901	814
Total Expenses	4.2%	101	97	1,766	1,804	2,632	2,182
Total profit before tax	-16.7%	11	13	115	75	108	106
Current tax	-25.7%	2.65	3.22	1.34	0	8.58	28
Deferred tax	0.8%	-0.23	-0.24	25	27	29	3.11
Tax expense	-28.3%	2.42	2.98	27	27	37	31
Net profit (loss) for the period	-19%	8.13	9.8	-	-	-	-
Reserve excluding revaluation reserves	-	0	-	954	965	0	0
Earnings Per Share, Basic	-23.3%	7.79	9.85	12.71	6.69	9.74	10.34
Earnings Per Share, Diluted	-23.3%	7.79	9.85	12.71	6.69	9.74	10.34

Description	(%) Q/Q	Dec-2021	Sep-2021	Jun-2021	Mar-2021	Dec-2020	Sep-2020
Revenue From Operations	17.1%	639	546	416	633	541	426
Other income	-74.3%	5.89	20	3.76	5.01	6.11	13
Cost of Materials	12.5%	271	241	192	239	216	176
Purchases of stock-in-trade	-	0	0	0	0	0	0
Employee Expense	10%	67	61	63	67	62	54
Finance costs	-6.2%	16	17	16	15	19	19
Other expenses	37.8%	216	157	167	178	153	142
Total Expenses	15.2%	599	520	403	582	497	406
Total profit before tax	-4.3%	45	47	17	57	51	33
Current tax	-49.5%	7.57	14	5.8	13	3.46	-14.71
Deferred tax	509.8%	9.11	2.33	0.13	11	12	12
Tax expense	6.7%	17	16	5.93	24	15	-3.12
Reserve excluding revaluation reserves	-	-	-	-	954	-	-
Earnings Per Share, Basic	-8.1%	4.4	4.7	1.74	4.77	5.08	5.04
Earnings Per Share, Diluted	-8.1%	4.4	4.7	1.74	4.77	5.08	5.04

Cash and cash equivalents	742.1%
Current investments	-
Inventories	-102.4%
Reserves and surplus	90.4%
Total current assets	73.9%
Non-current investments	792%
Total non-current assets	0%
Total assets	45.6%
Total non-current liabilities	-26.1%
Total current liabilities	20%
Total equity and liabilities	45.6%

Description	(%) Q/Q	Sep-2025	Mar-2025	Mar-2024	Sep-2023	Sep-2021	Mar-2021
Cash and cash equivalents	751.1%	73	9.46	13	21	5.54	3.74
Fixed assets	-	-	-	18	17	-	-
Inventories	-12.2%	37	42	21	23	525	436
Reserves and surplus	90.4%	100	53	44	38	-	-
Total current assets	74.7%	153	88	69	68	879	886
Non-current investments	440%	3.43	1.45	4.93	0.01	11	11
Total non-current assets	1.7%	61	60	27	22	2,110	1,970
Total assets	44.9%	214	148	97	90	2,989	2,856
Total non-current liabilities	-26.1%	18	24	3.99	6.48	1,078	960
Total current liabilities	20%	73	61	38	35	661	663
Total equity and liabilities	44.9%	214	148	97	90	2,989	2,856

Profit Before Extraord. Items And Tax	-
Finance costs	-
Depreciation	-
Total adjustments to profit/loss	-
Change in inventories	-
Change in trade receivables	-
Change in trade payables	-
Adjustments for Provisions	-
Total adj. for working capital	-
Net Cashflows From Operations	-
Interest received	-
Income taxes paid (refund)	-
Other inflows/outflows of cash	-
Net Cashflows From Operating Activities	-
Proceeds from sales of intangible assets	-
Interest received	-
Other inflows/outflows of cash	-
Net Cashflows From Investing Activities	-
Proceeds from borrowings	-
Interest paid	-
Net Cashflows From Financing Activities	-
Net change in cash and cash eq.	-

HSIL - Hemant Surgical Industries Limited Share Price

Valuation

Profitability

HSIL - Hemant Surgical Industries Limited Share Price

Valuation

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Important Disclosure & Data Context

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Important Disclosure & Data Context